Stock listing
NASDAQ:FLAC Frazier Lifesciences Acquisition Corp Stock
Follow Frazier Lifesciences Acquisition Corp into a list and get an email when it puts out news.
Last close · NASDAQ:FLAC
$10.35 USD
Close on Nov 23, 2022 · No longer trades
- Lowest – highest close
- $9.38 – $10.80 USDSince Feb 8, 2021 · lowest Nov 9, 2022 · highest Feb 8, 2021
Delisted NASDAQ:FLAC no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:FLAC
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Frazier Lifesciences Acquisition Corp on 6ix
- Decks
- 2 decks · latest Jul 25, 2022
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| SPAC Merger (July 2022) | SPAC merger | 53 slides | Jul 25, 2022 |
| SPAC Merger (July 2022) | SPAC merger | 53 slides | Jul 25, 2022 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| James N Topper Other companies: Attovia Therapeutics, Inc. (Director · Since at least Aug 4, 2026); NewAmsterdam Pharma Company N.V. (Director · Since at least Dec 29, 2023); Phathom Pharmaceuticals, Inc. (Director · Since at least Oct 24, 2019); Entasis Therapeutics Holdings Inc (Director · Sep 25, 2018 – Jan 18, 2019 · Past); Aptinyx Inc (Director · Jun 20, 2018 – Mar 31, 2020 · Past); Allena Pharmaceuticals Inc (Director · Nov 1, 2017 – Nov 17, 2020 · Past); Alpine Immune Sciences Inc (Director · Jul 24, 2017 – May 18, 2024 · Past); AnaptysBio, Inc. (Director · Jan 25, 2017 – Jan 6, 2023 · Past); Sierra Oncology Inc (Director · Jul 15, 2015 – Feb 14, 2017 · Past); Portola Pharmaceuticals Inc (Director · May 21, 2013 – Jun 5, 2013 · Past); Amicus Therapeutics Inc (Director · Jun 15, 2010 – Jun 12, 2014 · Past) | Chief Executive Officer, Director · Dec 8, 2020 – Dec 11, 2020 · Past |
| Patrick J Heron Other companies: MBX Biosciences, Inc. (Director · Since at least Sep 12, 2024); Hillevax Inc (Director · Since at least Apr 28, 2022); Arcutis Biotherapeutics, Inc. (Director · Since at least Jan 30, 2020); Mirum Pharmaceuticals, Inc. (Director · Since at least Jul 17, 2019); Imago Biosciences Inc (Director · Jul 15, 2021 – Jul 20, 2021 · Past); Vaxcyte, Inc. (Director · Jun 11, 2020 – Jun 2, 2021 · Past); Passage Bio, Inc. (Director · Feb 27, 2020 – Mar 3, 2020 · Past); Collegium Pharmaceutical, Inc. (Director · May 6, 2015 – Sep 10, 2015 · Past); Tobira Therapeutics Inc (Director · May 4, 2015 – Nov 1, 2016 · Past); Cidara Therapeutics Inc (Director · Apr 14, 2015 – Apr 20, 2015 · Past); Trubion Pharmaceuticals Inc (Director · Oct 23, 2006 – Oct 23, 2006 · Past) | Director · Dec 8, 2020 – Dec 11, 2020 · Past |
| Carol G. Gallagher Other companies: TRex Bio, Inc. (Lead Independent Director · Since at least Nov 5, 2026); PMV Pharmaceuticals, Inc. (Director · Since at least Nov 3, 2022); Atara Biotherapeutics, Inc. (Director · Since at least Oct 15, 2014); Certara, Inc. (Director · Jun 15, 2021 – Jun 15, 2021 · Past); Metacrine Inc (Director · Sep 15, 2020 – Sep 15, 2020 · Past); Annexon, Inc. (Director · Jul 23, 2020 – Jul 23, 2020 · Past); Turning Point Therapeutics Inc (Director · Jul 24, 2019 – Aug 17, 2022 · Past); Tempest Therapeutics, Inc. (Director · Dec 7, 2018 – Jun 22, 2020 · Past); AnaptysBio, Inc. (Director · Jan 25, 2017 – Feb 2, 2018 · Past); Anadys Pharmaceuticals Inc (SVP, Corp Dev & Comm Affairs · Mar 15, 2007 – May 16, 2007 · Past) | Director · Dec 8, 2020 – Nov 22, 2022 · Past |
| Michael Bigham Other companies: Adamas Pharmaceuticals Inc (Director · Sep 20, 2016 – Nov 24, 2021 · Past); Paratek Pharmaceuticals Inc (Exec. Chairman of the Board, Director · Oct 30, 2014 – Sep 21, 2023 · Past); Supernus Pharmaceuticals, Inc. (Director · Apr 30, 2012 – Mar 20, 2013 · Past); Xenogen Corp (Director · Aug 9, 2006 – Aug 9, 2006 · Past) | Director · Dec 8, 2020 – Nov 22, 2022 · Past |
| Robert Baltera Jr Other companies: Palisade Bio, Inc. (Director · Since at least Jun 10, 2026); Imago Biosciences Inc (Director · Jul 15, 2021 – Jan 11, 2023 · Past); Xencor, Inc. (Director · Dec 2, 2013 – Jun 23, 2016 · Past); VivoSim Labs, Inc. (Director · Mar 13, 2012 – Jul 26, 2018 · Past) | Director · Dec 8, 2020 – Nov 22, 2022 · Past |
| David Joseph Topper Other companies: Arcutis Biotherapeutics, Inc. (Chief Financial Officer · Apr 10, 2024 – Apr 2, 2025 · Past); Engility Holdings Inc (Director · May 24, 2018 – Jan 14, 2019 · Past) | Chief Financial Officer, Director · Dec 8, 2020 – Nov 22, 2022 · Past |
| Krishna R Polu Other companies: Equillium, Inc. (Chief Medical Officer · Oct 11, 2018 – Apr 22, 2020 · Past) | Director · Dec 8, 2020 – Nov 22, 2022 · Past |
| Gordon Empey | Vice President&General Counsel · Dec 8, 2020 – Dec 8, 2020 · Past |
| Max N Nowicki | Vice President, Acquisitions · Dec 8, 2020 – Dec 8, 2020 · Past |
Log in to ask 6ix AI your own questions about Frazier Lifesciences Acquisition Corp.